Drugs / HM2002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06621576 | Sep 2024 → May 2025 | heart failure, myocardial ischemia | Ruijin Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HM2002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06621576 ↗ |
| Modality | Other / unclassified | “Circular RNA-HM2002 Injection” NCT06621576 ↗ |
| Route | Other | “through the epicardium” NCT06621576 ↗ |